Dose-optimization study of 3 starting doses of ponatinib: Long-term results from the OPTIC trial Meeting Abstract
| Authors: | Cortes, J.; Deininger, M.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; McCloskey, J.; Hochhaus, A.; Rousselot, P.; Rosti, G.; de Lavallade, H.; Turkina, A.; Maness, L.; Talpaz, M.; Mauro, M.; Lu, V.; Vorog, A.; Apperley, J. |
| Abstract Title: | Dose-optimization study of 3 starting doses of ponatinib: Long-term results from the OPTIC trial |
| Meeting Title: | 12th Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) |
| Keywords: | cml; chronic myeloid leukemia; tyrosine kinase inhibitor; dose-response; ponatinib; bcr::abl1 |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Sep 4-7 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S373 |
| Language: | English |
| ACCESSION: | WOS:001315579603148 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01317-X |
| Notes: | Meeting Abstract: CML-425 -- Source: Wos |
